Terry D. Butters
Oxford, ENG OX13QU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease*.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: April 23, 2021
Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 06, 2020
Iminosugars: A host-targeted approach to combat Flaviviridae infections.
Journal: Antiviral research
Published: May 19, 2020
Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach.
Journal: World journal of urology
Published: December 03, 2019
The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Journal: Glycoconjugate journal
Published: December 14, 2017
Serum glycomarkers of endoplasmic reticulum and lysosomal-endosomal system stress in human healthy aging and diseases.
Journal: Ukrainian biochemical journal
Published: December 14, 2017
Structural essentials for β-N-acetylhexosaminidase inhibition by amides of prolines, pipecolic and azetidine carboxylic acids.
Journal: Organic & biomolecular chemistry
Published: October 14, 2016
"Three sources and three component parts" of free oligosaccharides.
Journal: Ukrainian biochemical journal
Published: March 31, 2015
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
Journal: Viruses
Published: March 16, 2015
N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
Journal: Organic & biomolecular chemistry
Published: October 04, 2014
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.
Journal: The Journal of clinical investigation
Published: September 16, 2014
Last Updated: 09/26/2026